Over the past 12 months, 0 insiders at SpringWorks Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on SWTX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 25 | Badreddin EdrisChief Operating Officer | SELL | 12.1K | $56.20 | $655K |
| Mar 3, 25 | Saqib IslamChief Executive Officer | SELL | 23.6K | $56.89 | $1.3M |
| Feb 20, 25 | Bhavesh AsharChief Commercial Officer | SELL | 1.0K | $61.19 | $62K |
| Feb 20, 25 | Saqib IslamChief Executive Officer | SELL | 24.3K | $61.24 | $1.5M |
| Feb 20, 25 | Daniel LynchDirector | SELL | 44.0K | $61.24 | $2.6M |
| Feb 14, 25 | Saqib IslamChief Executive Officer | SELL | 10.7K | $59.92 | $639K |
| Feb 14, 25 | Daniel LynchDirector | SELL | 400 | $60.00 | $24K |
| Feb 10, 25 | Badreddin EdrisChief Operating Officer | SELL | 30.0K | $53.13 | $1.6M |
| Feb 10, 25 | Julie HambletonDirector | SELL | 13.8K | $53.01 | $730K |
| Feb 10, 25 | Saqib IslamChief Executive Officer | SELL | 48.0K | $53.30 | $2.6M |
| Feb 10, 25 | Daniel LynchDirector | SELL | 69.8K | $55.51 | $3.7M |
| Feb 10, 25 | Daniel PichlChief People Officer | SELL | 13.8K | $57.15 | $729K |
| Dec 3, 24 | Badreddin EdrisChief Operating Officer | SELL | 12.0K | $42.24 | $500K |
| Dec 2, 24 | Saqib IslamChief Executive Officer | SELL | 45.0K | $41.85 | $1.9M |
| Sep 3, 24 | Badreddin EdrisChief Operating Officer | SELL | 12.3K | $42.08 | $493K |
| Sep 3, 24 | Saqib IslamChief Executive Officer | SELL | 32.4K | $42.07 | $1.3M |
| Jun 3, 24 | Badreddin EdrisChief Operating Officer | SELL | 11.8K | $42.04 | $464K |
| Jun 3, 24 | Julie HambletonDirector | SELL | 2.9K | $42.09 | $116K |
| Jun 3, 24 | Saqib IslamChief Executive Officer | SELL | 33.2K | $42.09 | $1.3M |
| Feb 16, 24 | Daniel PichlChief People Officer | SELL | 15.0K | $50.10 | $752K |
| Feb 5, 24 | Bhavesh AsharChief Commercial Officer | SELL | 4.8K | $49.32 | $238K |
| Feb 2, 24 | Bhavesh AsharChief Commercial Officer | SELL | 1.7K | $46.37 | $74K |
| Feb 2, 24 | Daniel PichlChief People Officer | SELL | 14.2K | $46.44 | $628K |
| Jul 19, 23 | Julie HambletonDirector | SELL | 2.4K | $29.31 | $71K |
| Jun 20, 23 | Julie HambletonDirector | SELL | 2.4K | $26.92 | $65K |
| Mar 16, 23 | Jeffrey Lawrence SchwartzDirector | SELL | 1.75M | $28.50 | $49.9M |
| Mar 15, 23 | Julie HambletonDirector | SELL | 1.1K | $31.50 | $35K |
| Jan 26, 23 | Daniel PichlChief People Officer | SELL | 858 | $31.00 | $27K |
| Sep 12, 22 | Orbimed Capital Gp VI LlcTenPercentOwner | SELL | 123.9K | $31.98 | $4.0M |
| Aug 9, 22 | Orbimed Advisors LlcTenPercentOwner | SELL | 69.6K | $37.47 | $2.6M |
| Aug 8, 22 | Orbimed Advisors LlcTenPercentOwner | SELL | 205.0K | $38.33 | $7.9M |
| Oct 20, 21 | Saqib IslamChief Executive Officer | SELL | 10.1K | $58.67 | $592K |
| Oct 19, 21 | Saqib IslamChief Executive Officer | SELL | 14.1K | $58.81 | $828K |
| Oct 18, 21 | Saqib IslamChief Executive Officer | SELL | 38.3K | $58.59 | $2.2M |
| Oct 13, 21 | L. Mary SmithChief Development Officer | SELL | 10.0K | $55.97 | $560K |
| Aug 10, 21 | Bc Sw, LpTenPercentOwner | SELL | 1.00M | $70.25 | $70.3M |
Over the past 12 months, insiders at SpringWorks Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on SWTX, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at SpringWorks Therapeutics, Inc. filed open-market SEC Form 4 transactions on SWTX over the last 12 months.
InsiderTape plots every SWTX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every SpringWorks Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →